Intravitreal bevacizumab combined with panretinal photocoagulation in the treatment of open angle neovascular glaucoma

European Journal of Ophthalmology

Volumn 19, Issue 6, 2009, Pages 1028-1033

  Ciftci, Suleyman ^a   Sakalar, Yildirim Bayezit ^b   Unlu, Kaan ^b   Keklikci, Ugur ^b   Caca, Ihsan ^b   Dogan, Eyup ^b  

^a Batman Regional Government Hospital   (Turkey)

^b DICLE UNIVERSITY   (Turkey)

Author keywords

Bevacizumab; Neovascular glaucoma; Panretinal photocoagulation

Indexed keywords

ACETAZOLAMIDE; BEVACIZUMAB; BRIMONIDINE; DORZOLAMIDE PLUS TIMOLOL; LATANOPROST; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; BRAIN INFARCTION; CLINICAL ARTICLE; DRUG EFFICACY; ENDOPHTHALMITIS; EYE SYNECHIA; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; INTRAOCULAR PRESSURE; LASER COAGULATION; MALE; NEOVASCULAR GLAUCOMA; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; UVEITIS; VISUAL ACUITY; DIABETIC RETINOPATHY; DRUG ANTAGONISM; FOLLOW UP; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OCULOPLETHYSMOGRAPHY; PROSPECTIVE STUDY; RETINA VEIN OCCLUSION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; COMBINED MODALITY THERAPY; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA, NEOVASCULAR; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; LASER COAGULATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETINAL VEIN OCCLUSION; TONOMETRY, OCULAR; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 73949136339     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210901900620     Document Type: Article

References (17)

1. Tripathi RC, Li J, Tripathi BJ, Chalam KV, Adamis AP. Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology 1998; 105: 232-7.
2. Tolentino MJ, Miller JW, Gragoudas ES, Chatzistefanou K, Ferrara N, Adamis AP. Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate. Arch Ophthalmol 1996; 114: 964-70.
3. Adamis AP, Shima DT, Tolentino MJ, et al. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Arch Ophthalmol 1996; 114: 66-71.
4. Sivak-Callcott JA, O'Day DM, Gass JD, Tsai JC. Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology 2001; 108: 1767-76.
5. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004; 25: 581-611.
6. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350: 2335-42.
7. Iliev ME, Domig D, Wolf-Schnurrbursch U, Wolf S, Sarra GM. Intravitreal bevacizumab (Avastin®) in the treatment of neovascular glaucoma. Am J Ophthalmol 2006; 142: 1054-6.
8. Kahook MY, Schuman JS, Noecker RJ. Intravitreal bevacizumab in a patient with neovascular glaucoma. Ophthalmic Surg Lasers Imaging 2006; 37: 144-6.
9. Silva PJ, Jorge R, Costa RA, Rodrigues MLV, Scott IU. Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma. Acta Ophthalmol Scand 2006; 84: 556-7.
10. Chilov MN, Grigg JR, Playfair TJ. Bevacizumab (Avastin) for the treatment of neovascular glaucoma. Clin Exp Ophthalmol 2007; 35: 494-6.
11. Vatavuk Z, Bencic G, Mandic Z. Intravitreal bevacizumab for neovascular glaucoma following central retinal artery occlusion. Eur J Ophthalmol 2007; 17: 269-71.
12. Yazdani S, Hendi K, Pakravan M. Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma. J Glaucoma 2007; 16: 437-9.
13. Grisanti S, Biester S, Peters S, et al. Intracameral bevacizumab for iris rubeosis. Am J Ophthalmol 2006; 142: 158-60.
14. Davidorf FH, Mouser JG, Derick RJ. Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection. Retina 2006; 26: 354-6.
15. Adamis AP, Shima DT, Tolentino MJ, et al. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Arch Ophthalmol 1996; 114: 66-71.
16. Duker JS, Brown GC. The efficacy of panretinal photo-coagulation for neovascularization of the iris after central retinal artery obstruction. Ophthalmology 1989; 96: 92-5.
17. Ehlers JP, Spirn MJ, Lam A et al. Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma. Retina 2008; 28: 696-702.